C7
C7 (complement C7, formerly complement component 7) is a serum glycoprotein of the terminal complement pathway. It joins C5b, C6, C8 and C9 in the membrane attack complex and acts as the membrane anchor that lets the complex insert into target cell membranes. Browse Assay Genie's current range of C7 research reagents below, or read on for the biology behind the target.
C7 is a component of the membrane attack complex (MAC), a multiprotein assembly activated by the complement cascade. The MAC inserts into a target cell membrane and forms a pore, which leads to membrane rupture and cell lysis. MAC formation starts when C5 is cleaved into C5b, in response to the classical, alternative, lectin and GZMK complement pathways. Complement as a whole drives phagocytosis and breakdown of pathogens, and produces signalling that strengthens the adaptive immune system. Within the MAC, C7 serves as a membrane anchor. It associates with C5b and C6 to form the C5b-7 complex, a lipophilic precursor of the MAC that binds the outer leaflet of the membrane and reduces the energy needed for membrane bending.
The C7 gene encodes a serum glycoprotein that works with C5b, C6, C8 and C9 in the terminal complement pathway of the innate immune system. The C7 protein contains a cholesterol-dependent cytolysin/membrane attack complex/perforin-like (CDC/MACPF) domain. It belongs to the complement C6/C7/C8/C9 family, part of a large group of structurally related pore-forming molecules involved in host immunity and bacterial pathogenesis. C7 starts MAC formation by binding the C5b-C6 subcomplex and then inserts into the phospholipid bilayer. UniProt records it as both secreted and located at the target cell membrane.
HGNC places C7 in the sushi domain containing, complement system activation components and membrane attack complex gene groups, and lists its previous name as complement component 7. Mutations in the gene are associated with a rare disorder called C7 deficiency. The mouse ortholog is also named C7, and the rat ortholog is listed as Oxr1.
C7 is part of the terminal complement pathway, which feeds into pathogen breakdown and strengthens the adaptive immune response.
C7 binds the C5b-C6 subcomplex and anchors the C5b-7 precursor in the membrane, which makes it a useful point for studying pore formation.
As a member of a pore-forming family involved in host immunity and bacterial pathogenesis, C7 informs studies of lytic defence mechanisms.
Mutations in the C7 gene are associated with the rare disorder C7 deficiency, so C7 is relevant to inherited terminal pathway defects.
C7 is a component of the membrane attack complex. It binds the C5b-C6 subcomplex to form C5b-7, then inserts into the phospholipid bilayer as a membrane anchor. This allows the complex to form a pore in the target cell membrane, leading to lysis.
The HGNC full name is complement C7, and UniProt calls the protein complement component C7. The previous HGNC name was complement component 7. No alternative gene symbols are listed. The protein is a serum glycoprotein that is also found at the target cell membrane.
Mutations in the C7 gene are associated with a rare disorder called C7 deficiency. The mouse ortholog is also named C7, while the rat ortholog is listed as Oxr1. Check the datasheet of any product for its validated reactivity.
Other membrane attack complex components and terminal complement pathway proteins that work alongside C7.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P10643; product specifications from Assay Genie datasheets.